Miriam John - Leidos Holdings Independent Director
| LDOS Stock | USD 134.85 0.00 0.00% |
Director
Dr. Miriam E. John is an Independent Director of the Company. Dr. John retired from Sandia National Laboratories, a science and engineering laboratory, after serving from 1982 to 2006 in a number of managerial and technical roles, most recently of which was as Vice President of Sandias California Division. Dr. John is a member of the Department of Defenses Defense Science Board and Vice Chairman of its Threat Reduction Advisory Committee. She was elected to the American Association for the Advancement of Science Committee on Science and Public Policy and is the past chair of the National Academies Naval Studies Board. She also serves on the boards of a number of federally funded national security laboratories, including MIT Lincoln Lab. She is a Senior Fellow and past Chair of the California Council on Science and Technology. She has also been elected a National Associate of the National Academies and is the recipient of the Navys Superior Public Service Award and the Department of Defenses Eugene G. Fubini Award for her significant and sustained contributions in an advisory capacity to the Department. since 2007.
| Age | 72 |
| Tenure | 18 years |
| Address | 1750 Presidents Street, Reston, VA, United States, 20190 |
| Phone | 571 526 6000 |
| Web | https://www.leidos.com |
Leidos Holdings Management Efficiency
The company has return on total asset (ROA) of 0.0879 % which means that it generated a profit of $0.0879 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.287 %, meaning that it created $0.287 on every $100 dollars invested by stockholders. Leidos Holdings' management efficiency ratios could be used to measure how well Leidos Holdings manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.14 in 2025. Return On Capital Employed is likely to drop to 0.11 in 2025. At this time, Leidos Holdings' Non Currrent Assets Other are comparatively stable compared to the past year. Intangible Assets is likely to gain to about 581 M in 2025, whereas Non Current Assets Total are likely to drop slightly above 5.2 B in 2025.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Lee Adrean | Fidelity National Information | 67 | |
| Thomas Perna | Broadridge Financial Solutions | 68 | |
| Charles Revoile | CACI International | 85 | |
| Robert Duelks | Broadridge Financial Solutions | 65 | |
| Brian Stevens | Genpact Limited | 57 | |
| Karen Dykstra | Gartner | 61 | |
| CeCelia Morken | Genpact Limited | 63 | |
| Carol Lindstrom | Genpact Limited | 67 | |
| Lisa Hook | Fidelity National Information | 63 | |
| Robert Bedingfield | Science Applications Internatio | 71 | |
| Tamara Franklin | Genpact Limited | 54 | |
| Gregory Johnson | CACI International | 74 | |
| Ellen Alemany | Fidelity National Information | 65 | |
| Jeffrey Stiefler | Fidelity National Information | 73 | |
| William Jews | CACI International | 68 | |
| James Pavitt | CACI International | 74 | |
| Garth Graham | Science Applications Internatio | 45 | |
| Anne Fuchs | Gartner | 73 | |
| Mark Nunnelly | Genpact Limited | 61 | |
| John Hogan | Broadridge Financial Solutions | 76 | |
| Laura Conigliaro | Genpact Limited | 75 | |
Management Performance
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.0879 |
Leidos Holdings Leadership Team
Elected by the shareholders, the Leidos Holdings' board of directors comprises two types of representatives: Leidos Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Leidos. The board's role is to monitor Leidos Holdings' management team and ensure that shareholders' interests are well served. Leidos Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Leidos Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amy Smith, Senior Affairs | ||
| Daniel Antal, General Counsel | ||
| Gerard Fasano, Executive Officer | ||
| Roger Krone, Chairman, CEO, Member of Classified Bus. Oversight Committee and Member of Ethics and Corporate Responsibility Committee | ||
| Susan Stalnecker, Independent Director | ||
| Christopher Cage, Senior Vice President, Chief Accounting Officer, Corporate Controller | ||
| Melissa Koskovich, SVP Marketing | ||
| Stephen Cook, President Group | ||
| Stuart Davis, Senior Relations | ||
| Surya Mohapatra, Independent Director | ||
| Paul Engola, Chief Human Resource Officer, Executive Vice President, Head of Business Partnerships | ||
| Noel Williams, Independent Director | ||
| Randy Phillips, Sr Devel | ||
| Mary Schmanske, Senior Vice President and Presidentident - Intelligence Group | ||
| Thomas Bell, CEO Director | ||
| Gary May, Independent Director | ||
| MD Kosiak, Chief Officer | ||
| Jerald Howe, Executive Vice President General Counsel | ||
| Gregory Dahlberg, Independent Director | ||
| Harry Kraemer, Independent Director | ||
| Vice Lewis, Senior Maritime | ||
| Srini Iyer, Chief Group | ||
| James Carlini, Chief Officer | ||
| Patrick Shanahan, Independent Director | ||
| Jason Albanese, Senior Development | ||
| Thomas Downey, Chief VP | ||
| James Moos, Group President - Civil Group | ||
| Roy Stevens, President - Intelligence Group | ||
| Robert Shapard, Lead Independent Director | ||
| Peter Berl, Senior President | ||
| Maureen Waterston, Chief Human Resource Officer | ||
| Miriam John, Independent Director | ||
| Frank Kendall, Independent Director | ||
| Kimberly Rupert, Senior Officer | ||
| Rick Reynolds, Senior Group | ||
| David Fubini, Independent Director | ||
| Gerald Fasano, Executive Vice President, President - Defense Group | ||
| Steve Cook, Group President - Dynetics | ||
| Daniel IV, Chief SVP | ||
| Leslie Fautsch, Chief Officer | ||
| Carly Kimball, Senior Vice President Chief Accounting Officer, Corporate Controller | ||
| Terry Phillips, Senior Vice President Chief Security Officer | ||
| David King, Group President - Dynetics | ||
| Elizabeth Porter, Group President - Health Group | ||
| Raymond JD, Senior Counsel | ||
| Robert Kovarik, Independent Director | ||
| James Reagan, Chief Financial Officer, Executive Vice President | ||
| Simon Fovargue, Chief Europe |
Leidos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Leidos Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.29 | ||||
| Return On Asset | 0.0879 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 22.12 B | ||||
| Shares Outstanding | 128.21 M | ||||
| Shares Owned By Insiders | 0.60 % | ||||
| Shares Owned By Institutions | 80.62 % | ||||
| Number Of Shares Shorted | 5.86 M | ||||
| Price To Earning | 22.14 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Leidos Stock Analysis
When running Leidos Holdings' price analysis, check to measure Leidos Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leidos Holdings is operating at the current time. Most of Leidos Holdings' value examination focuses on studying past and present price action to predict the probability of Leidos Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leidos Holdings' price. Additionally, you may evaluate how the addition of Leidos Holdings to your portfolios can decrease your overall portfolio volatility.